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ABSTRACT
THE ROLE OF PORPHYROMONAS GINGIVALIS IN THE REGULATION OF
EPITHELIAL-MESENCHYMAL TRANSITION MARKERS IN MIGRATION.
Akintunde Ojo
December 3, 2014.
A relationship between periodontal disease and oral squamous cell carcinoma (OSCC)
has been demonstrated in recent studies. Porphyromonas gingivalis’ antigen have been
found in oral cancer cells. The embryonic program “epithelial-mesenchymal transition”
(EMT) is thought to trigger cancer invasion by allowing tumor cell propagation. The
objective of this study was to examine the role of P. gingivalis in the expression of ZEB1,
vimentin, and repression of miRNA-200 family as EMT prognostic markers in cancer
cell metastasis. Human telomerase immortalized gingival keratinocytes (TIGK) cells
were challenged with P. gingivalis strain ATCC 33277 in vitro for 24h at MOI 50 and
100. Expression of ZEB1, and vimentin mRNA levels was determined using qRT-PCR.
The expression of ZEB1 and vimentin was up regulated 2.5-fold, and 3-fold
respectively, while that of miRNA-200 family was repressed in P. gingivalis infected
TIGK cells compared to controls. P. gingivalis infected cells invaded Matrigel-coated
Transwell membrane compared to non-infected cells. Knockdown of ZEB1
reduced the invasiveness of P. gingivalis infected TIGK cells. Thus, the presence of P.
gingivalis in the periodontium of cancer patients may contribute significantly to the
overexpression of ZEB1, and vimentin as crucial promoters of oral squamous cell cancer
invasion.
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CHAPTER I
INTRODUCTION
1.1 Oral Squamous Cell Carcinoma
Oral cancer has been described as the sixth most common cancer worldwide [1].
Squamous cell carcinoma of the oral cavity constitutes about ninety percent of all oral
malignancies [2]. They can affect any site of the oral mucosa, the tongue and the floor of
the mouth are the most commonly affected areas [3]. Prognosis of oral squamous cell
carcinoma (OSCC) remains poor even with advances in diagnostic techniques and
improvement in treatment modalities, this is mainly due owing to the high-rate of local
and regional recurrence and to the development of new malignant changes within the
original field of precancerisation [4].
1.1.1 Oral Squamous cell Carcinoma Epidemiology
Oral SCC affects men more frequently than women (M:F = 1.5:1), this is due to the fact
that men indulge in more high-risk habits than women [5]. The probability of developing
OSCC increases with the period of exposure to risk factors, and increasing age adds the
further dimension of age-related mutagenic and epigenetic changes. In the USA the
median age of diagnosis of OSCC is 62 years. However, the incidence of OSCC in
persons under the age of 45 is increasing [6].
In Western countries OSCC affects the tongue in 20% - 40% of cases and the floor of the
mouth in 15% - 20% of the cases, and together these sites account for about 50% of all
cases of OSCC [3, 7]. The gingivae, palate, retro-molar area, buccal and labial mucosa
are oral sites less frequently affected [6]. The ventral surface of the tongue and the floor
1

of the mouth are sites most commonly affected by SCC because they are lined by thin
non-keratinized epithelium [8]. The mean 5-year survival rate of persons with OSCC is
about 50% with no gender difference; but black persons have a lower five year survival
rate than persons of other races [6, 8].
1.1.2 Oral Squamous Cell Carcinoma Risk Factors
OSCC is considered to be a multi-causal disease inﬂuenced by the interrelationships
among various etiologic factors, including smoking, alcohol consumption, dietary
micronutrient deﬁciency, occupational activity, external agent exposure, genetic
susceptibility, and infection. The most important risk factors for OSCC are use of
tobacco or betel quid and the regular drinking of alcoholic beverages [1].The chief risk
factors for oral squamous cell carcinoma are smoking (especially > 2 packs/day) and
alcohol use. The combination of both factors seems to enhance the carcinogenic effect,
but nearly 15 to 20% of the cases occur in patients without these traditional risk factors
[9]. The highest incidence and prevalence of oral SCC is found in the Indian
subcontinent where the risk of developing oral SCC is increased by the very prevalent
habits of chewing tobacco, betel quid and areca-nut [10].
Cancers of the head and neck are usually caused by tobacco and alcohol, but recent
studies show that about 25% of mouth and 35% of throat cancers in the United States of
America are associated with Human Papilloma Virus (HPV). Increased incidence of
oropharyngeal cancers in the USA have been attributed to HPV infection in recent studies
[11, 12]. The discussion about human papilloma virus (HPV) in OSCC points at a general
role of infection for the development of oral carcinomas.
Studies have also demonstrated a signiﬁcant relationship between periodontitis and
OSCC. A very recent epidemiological survey in 2012, showed that periodontitis was
markedly associated with orodigestive cancer mortality, while P. gingivalis, a major
2

periodontal pathogen, was identified as a specific and potentially independent microbial
factor to increase the risk of orodigestive cancer death [13]. P. gingivalis has been shown
to occur frequently in the mouth of oral cancer patients, its antigens have also been
detected in gingival squamous carcinoma tumors [14]. All these findings indicate the
possibility that the interactions of P. gingivalis with OSCC cells are involved in cancer
progression and metastasis.
1.2 Epithelial-Mesenchymal Transition
Epithelial-mesenchymal transition (EMT) is a multi-step morphogenetic process during
which epithelial cells down-regulate their epithelial properties and up-regulate
mesenchymal characteristics. Namely, static epithelial cells lose cell to cell junctions and
as a consequence they lose apico-basal polarity to become migratory mesenchymal-like
cells. This process of down-regulation of the epithelial phenotype mimics the normal
developmental process of gastrulation, in which cells from the epithelial sheet of the
ectoderm start to form the third germinal layer, the mesoderm, whose migratory cells are
called mesenchymal cells. Hence, this process is competently referred to as epithelialmesenchymal transition [15].
EMT is an essential and tightly controlled developmental process that plays a
fundamental role during embryogenesis, wound healing, and tissue repair [2]. EMT is
regulated by many signaling pathways, transcriptional factors, and post-transcriptional
factors.
1.2.1 Transcription Factors Regulating EMT
There are a number of known transcription factors that play vital roles in the regulation of
EMT. The most characterized are ZEB 1, ZEB 2, snail, slug and twist [16]. These
transcription factors mastermind the down-regulation of the epithelial junction proteins
E-cadherin, occludins, claudins, and connexins, and the up-regulation of the
mesenchymal proteins N-cadherin, vimentin, α- smooth muscle actin, fibronectin,
3

specific myosin isoforms, and matric metallo proteinases (MMPs) [17].
Expression of ZEB1 and ZEB2 are induced by factors such as TGF-β, hypoxic conditions
and inflammatory cytokines and many growth factors are all known to initiate EMT [18].
Like the two ZEB transcription factors, snail and slug can be induced by TGF-β, hypoxic
conditions and other EMT-related signaling pathways [19]. There is a significant overlap
in the regulatory signals of these transcription factors. Expression of ZEB factors is
regulated by Snail, Snail in turn also increases the stability of Twist which then activates
the transcription of Slug. This interaction network may be involved in the spatial and
temporal regulation of EMT [20].
1.2.2 EMT in Normal Development
During embryogenesis, multiple structures and organs including the palate, skeletal
muscle, derivatives of the neural crest and cardiac heart valves rely on EMT [21]. EMT
consists of a series of defined events. These include the degradation of the underlying
basement membrane, detachment from neighboring epithelial cells, alteration of cell
shape and cytoskeletal remodeling, invasion through the underlying basement membrane
and movement into the surrounding tissue [22].
Importantly, dysregulation of pathways involved in developmental EMT have been
correlated with embryonic defects in mice including cleft palate, as well as heart valve
and cranial facial and peripheral nervous system defects, thereby demonstrating that EMT
is a critical process in normal development [23].

4

Figure 1: EMTs give rise to progenitors of many organs and tissues.
(A) Epiblast cells that internalize at gastrulation give rise to different mesodermal and
endodermal populations from which a variety of cell types form. Embryonic cells undergoing
EMT are shown in green. Pt, platelets; B, T, and NK, lymphocytes; G, granulocytes; M,
macrophages. (B) In turn, the neural crest delaminates from the dorsal neural tube and will
generate neurons of the peripheral nervous system, glial and satellite cells, pigment cells,
odontoblasts, and the craniofacial cartilage, as well as other cell types. Adapted from J Clin
Invest. 2009.
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1.2.3 EMT in Cancer
Studies have shown the involvement of EMT in contexts outside development such as
wound healing, fibrosis and cancer. Excessive epithelial cell proliferation and
angiogenesis are hallmarks of the initiation and early growth of primary epithelial cancers
[24]. During cancer progression cancerous epithelial cells are thought to undergo EMT
and acquire stem cell-like properties, allowing individual cells to bud oﬀ the tumor mass,
invade the surrounding tissue, intravasate into lymph and blood vessels and ﬁnally
metastasize by forming distant, secondary tumors [25].
Cancer cells enhance their migratory and invasive capacity through the down-regulation
of epithelial markers involved in the maintenance of cell polarity and intercellular
adhesion, chiefly the inhibition of E-cadherin. The transcriptional repressor zinc-finger Ebox binding homeobox 1 (ZEB1) is a crucial inducer of EMT in various human tumors
[26].
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Figure 2. Contribution of EMT to cancer progression.
Progression from normal epithelium to invasive carcinoma goes through several stages. The
invasive carcinoma stage involves epithelial cells losing their polarity and detaching from the
basement membrane. The composition of the basement membrane also changes, altering cellECM interactions and signaling networks. The next step involves EMT and an angiogenic switch,
facilitating the malignant phase of tumor growth. Progression from this stage to metastatic cancer
also involves EMTs, enabling cancer cells to enter the circulation and exit the blood stream at a
remote site, where they may form micro- and macro-metastases, which may involve METs and
thus a reversion to an epithelial phenotype. Adapted from J Clin Invest. 2009.
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1.3 Zinc finger E-box-binding homeobox 1 (ZEB1).
ZEB proteins are sequence-specific DNA-binding transcription factors. In upper
vertebrates, the ZEB1 belongs to the ZFH family comprising ZEB1 (delta EF1) and
ZEB2 (Smad-interacting protein 1, SIP1) [27]. ZEB1 (also known as TCF8 and delta
EF1) and ZEB2 (also known as ZFXH1B and SMAD-interacting protein 1 [SIP1]) are
large transcription factors (124 and 136 kDa, respectively) containing two zinc-ﬁnger
domains, separated by a homeodomain. The zinc-ﬁnger structures are highly conserved
and allow DNA binding at E-boxes present within the promoter regions of target genes,
such as E-cadherin [28]. One of Zeb1 roles is to regulate the expression of E-Cadherin, a
crucial molecule in maintaining the characteristics of epithelial cells.
Enforced expression of ZEB factors in epithelial cells results in a rapid EMT associated
with a breakdown of cell polarity, loss of cell-cell adhesion and induction of cell motility.
Vise-versa, a knockdown of ZEB factors in undifferentiated cancer cells induces a
mesenchymal-to-epithelial transition (MET) [29]. Expression of ZEB1 promotes
metastasis of tumor cells in a mouse xenograft model, indicating a role for ZEB1 in
invasion and metastasis of human tumors [30]. As a repressor of E-cadherin, ZEB1 is not
expressed in normal epithelium or the tumor center of well-differentiated carcinomas
[31].
ZEB1 is induced by multiple signaling pathways including TGF-β, Notch, and canonical
Wnt (b-catenin/TCF4) [32]. The nuclear factor κB (NF-κB) pathway have also been
shown to play a role in mediating the process of EMT through the up-regulation of
8

transcription repressor function of ZEB1, which in turn represses the expression of the
miR-200 family by binding to E-box sequence of miR-200 promoter. Cell innate
immunity has been shown to be triggered by bacterial peptidoglycan leading to activation
of NF-κB, known as a master transcription factor in inflammatory responses following
microbial infection. This process thus leads to the NF-κB-dependent transcription of
multiple target genes including pro-inflammatory interleukin (IL)-1β, IL-6, IL-8 and
tumor necrosis factor α [33].

1.4 Vimentin
Vimentin, a 57-kDa protein, is one of the most widely expressed and highly conserved
proteins of the type III IF protein family. It is found in many mesenchymal and epithelia
tissues, tissue culture cells, and developing neuronal and astrocytic precursor cells of the
central nervous system. Vimentin is crucial for supporting and anchoring the position of
the organelles in the cytosol. It provides cells with a resilience absent from the
microtubule or actin filament networks, when under mechanical stress in vivo. It is also
responsible for maintaining cell integrity and for stabilizing cytoskeletal interactions [26].
Vimentin is expressed at sites of cellular elongation and is associated with a migratory
phenotype. Increased vimentin is frequently used as an EMT marker in cancer [26].
Cytoskeletal

intermediate filaments (IFs) undergo a significant compositional change as

epithelial cells, which normally express only keratin IFs (KIFs), initiate the expression of
vimentin IFs (VIFs). Because of this dramatic change in IF composition, VIF expression
has become a canonical marker of the EMT [34]. Recent observations have broadened the
9

relevance of the EMT and further emphasized that VIF assembly is a hallmark of these
changes. For example, VIF expression can be predictive of the recurrence and invasive
potential of prostate cancer cells and can be used to determine the origin of metastatic
breast carcinoma cells [35, 36].VIF expression has been reported to be also up-regulated
in model cell culture systems used to study wound healing [37].
Vimentin expression has been shown to be transcriptionally regulated by various factors.
Initiation of the transcription of EMT-related transcription factor families, including ZEB
(ZEB1 and ZEB2), the zinc finger Snail (SNAI1 and SNAI2) are critical in the upregulation of vimentin. It was reported that miR-506 inhibit TGFβ-induced EMT by
directly targeting vimentin in human breast cancer cell line. miR-30 miR-17-3p, miR-17,
miR-124 and miR-203 has also been reported to suppress the migratory ability and
invasiveness of breast cancer cell lines by directly targeting its 3′UTR [38, 39].
Vimentin expression may also play an important role in modulating an epithelial cell’s
response to mechanical stress during the EMT. Epithelial cells expressing VIFs are flatter
than normal epithelial cells expressing only KIFs. The height of cells above their growth
substrates has been shown to be a determining factor in the response of epithelial and
endothelial cells to shear stress; flatter cells are much less sensitive to shear stress relative
to taller, neighboring cell [40, 41]. The epithelial cell flattening induced by vimentin
expression may play a role in facilitating the ability of these cells to withstand a variety
of external mechanical forces. This may be a critical factor for the survival of metastatic
cells, which are exposed to abnormal physical stresses as they navigate from primary to
secondary tumor sites [42].
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Migrating epithelial cells in wound margins and deep epithelial ridges that had gained
mesenchymal features such as vimentin have an enhanced capability for speedy wound
closure. Significant delays in wound healing, attributable to a reduced migratory
capability of epithelial cells, are exhibited by vimentin-knockout mice [43].

1.5 Micro-Ribonucleic Acid (miRNA)
Less than a decade ago, miRNAs were considered relatively unimportant. Today,
miRNAs have been identified as important gene regulators that are involved in how and
when genes are turned on and off. The first miRNA, lin-4, was discovered in 1993 by
Lee and his colleagues in C. elegans [44]. Seven years later, a second small RNA was
identified in C. elegans, named let-7 When the genes were cloned they were identified to
code for two 21-22 nt long RNAs with an important role in developmental timing. Let-7
was thereafter identified in several vertebrates, including humans [45].
miRNAs are a recently discovered class of small nucleic acids (approximately 18-24 nt)
that negatively regulate gene expression by binding to the 3'-untranslated regions (3'UTR) of specific mRNAs. They have been identified in plants and animals and are highly
conserved [46]. Up to date, more than 700 miRNAs are identified in human. The name of
miRNAs found in the miR database includes 3 or 4 letters that designates the species
(e.g., "hsa" for Homo sapiens), while the core of the miRNA name is the designation
"miR" (denoting a mature sequence) followed by a unique identifying number [47].
Profiles of miRNA are highly informative because they reflect the developmental lineage
and differentiation state of tumors. A study performed has identified miRNAs that are
11

significantly differentially expressed between tumor tissue and normal tissue. Till now,
several miRNAs have been implicated in tumorigenesis and many are thought to behave
as tumour suppressors or oncogenes and are either up- or down- regulated [48].

1.5.1 miRNA as Gene Regulators
Each of the ∼400 miRNAs known to exist in mammalian cells has multiple targets,

making them powerful regulators of complex processes such as differentiation and cancer
progression. In mammals, the mature miRNA negatively regulates target mRNA by
either binding to imperfect complementary sites within the 3’- UTR of mRNA-targets, or
by targeting specific cleavage of homologous mRNAs. However, studies have indicated
that miRNAs can also down-regulate the expression of genes by base-pairing to the
coding region or 5’-UTR of some mRNAs [49, 50]. A perfect or almost perfect
complementarity to the target site can induce gene silencing via the RNA interference
pathway. By binding to imperfect complementary sites on the mRNA-target strand,
miRNAs inhibit translation and reduce protein levels of target genes without affecting
mRNA levels of these genes [51].
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Figure 3. Processing and mechanism of action of miRNA.
(1) Transcription of miRNA in the nucleus by RNA polymerase II to generate primary transcripts (primiRNAs). (2) Processing of transcripts by the Drosha/DGCR8 complex to generate pre-miRNAs. (3)
Transportation of the pre-miRNAs into the cytoplasm. (4) Processing of pre-miRNAs into duplexes that
contain the mature miRNA product. (5) Incorporation of one strand of miRNA duplex with the RNAinduced silencing complex (RISC), which directs miRNA targeting of mRNAs. (6) Partial sequence
complementarity between the miRNA and the target results in (a) translational repression, while complete
sequence complementarity leads to (b) translational degradation. Adapted from: Unraveling the complex
regulation of stem cells: implications for aging and cancer E J Oakley and G Van Zant.
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1.5.2 miRNA 200 family
The miR-200 family contains miR-200a, miR-200b, miR-200c, miR-141, and miR-429.
The five members of the miR-200 family are grouped in two independent transcriptional
units: a) miR-200b, miR-200a and miR-429 are clustered in an intergenic region of
chromosome 1; and b) miR-200c and miR-141 are located on chromosome 12, within the
intron of a noncoding RNA. Recent studies have shown that both clusters are subject to
epigenetic regulation in cancer and normal tissue. The miR-200 family opposes EMT by
directly targeting genes involved in motility and invasion [52, 53].

1.5.3 ZEB1/miR-200 feedback loop
Members of the miR-200 family have been shown to be major regulators of EMT through
the targeted silencing of the EMT-transcriptional inducers ZEB1, which in turn
transcriptionally repress miR-200 family in a double-negative feedback loop [54]. Recent
studies showed that miR-200 could repress ZEB1 expression through binding to a
sequence of the 3’-UTR of ZEB1 mRNA (ZEB1 3’ UTR contains eight miR-200 binding
sites) and that ZEB1 could directly bind to the promoter of the miR-200 gene cluster,
resulting in the repression of miR-200 expression and establishing a double-negative
feedback loop controlling the expression of ZEB1 and the miR-200 family during EMT
[54, 55].
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Figure 4. Epithelial-to-mesenchymal transition regulation by non-coding miRNAs.
The central role of miR-200 is to stabilize the epithelial state (green) by repressing negative
regulators of E-cadherin expression. In the epithelia state, miR-200 targets subunits of Polycomb
repressive complex 1 (PRC1) (BMI1) and PRC2 (SUZ12) as well as the transcription factors
ZEB1 and ZEB2. Transforming growth factor-β (TGFβ)-induced ZEB1, ZEB2 and homologue of
Snail (SNAI1) repress miR-200 and E-cadherin in negative fashion, thus promoting mesenchymal
fate (grey). Active miRNAs are indicated by Red boxes; active proteins by light blue boxes;
inactive genes/miRNAs by unboxed text; inactive processes are represented by grey lines.
PDCD4, programmed cell death 4; PTEN, phosphatase and tensin homologue; MET,
mesenchymal-to-epithelial transition; RISC, RNA-induced silencing complex. Adapted from:
Non-coding RNAs as regulators of embryogenesis. Andrea Pauli, John L. Rinn & Alexander F.
Schier Nature Reviews Genetics 12, 136-149 (February 2011).
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1.6 Porphyromonas gingivalis
Porphyromonas gingivalis is a Gram-negative anaerobe that has strongly been associated
with severe and chronic cases of periodontal disease [56]. It is a non-spore forming
bacterium, belonging to the phylum Bacteroidetes. This opportunistic pathogen is an
inhabitant of the sub-gingival crevice and is known to cause disease by disturbing the
host immune homeostasis (dysbiosis) [57]. P. gingivalis is an opportunistic pathogen that
can also exist in commensal harmony with the host. This bacterium, a member of the red
complex group of bacteria maintain a polymicrobial synergy with other bacteria in
initiating periodontitis [56].
P. gingivalis, is a prominent component of the oral microbiome and a successful
colonizer of the oral epithelium [58]. P. gingivalis can invade and survive within gingival
epithelial cells, and an intracellular location physically sequesters the organism from
recognition by the immune system [59]. The perturbation of epithelial cells by bacteria is
the first stage in the initiation of inflammatory and immune processes which eventually
cause destruction of the tissues surrounding and supporting the teeth which ultimately
result in tooth loss [60]. P. gingivalis can locally invade periodontal tissues and evade the
host defense mechanisms. In doing so, it utilizes a panel of virulence factors that cause
deregulation of the innate immune and inflammatory responses [61].
P. gingivalis can also penetrate deep into gingival tissue and degrade basement
membrane proteins. It adheres to, invades, remain viable, could replicate, and survive for
a long period within human epithelial cells. Adhesion of P. gingivalis to host cells
involves the interaction of bacterial cell-surface adhesins with receptors expressed on the
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surfaces of epithelial cells, this it achieves by exploiting host cell signaling pathways [62,
63]. The interaction between P. gingivalis fimbriae and its cognate receptor β-1 on
gingival epithelial cells surfaces can initiate signal transduction that leads to its uptake
into epithelial cells [63]. Destruction of gingival tissues by bacterial or host proteases
usually follows as a result. One other important characteristic of periodontal infection
induced by P. gingivalis is inflammation. This is as a result of neutrophil infiltration into
infected sites, continuous production of pro-inflammatory cytokines, such as IL-8,
appears to be important for the progression of periodontal infections and tissue
destruction [64] .
P. gingivalis is said to rapidly adhere to the host cell surface followed by internalization
via lipid rafts and incorporation of the bacterium into early phagosomes. P. gingivalis
activates cellular autophagy to provide a replicative niche while suppressing apoptosis.
The replicating vacuole contains host proteins delivered by autophagy that are used by
this asaccharolytic pathogen to survive and replicate within the host cell. When
autophagy is suppressed by 3-methyladenine or wortmannin, internalized P. gingivalis
transits to the phagolysosome where it is destroyed and degraded. For that reason, the
survival of P. gingivalis depends upon the activation of autophagy and survival of the
endothelial host cell, but the mechanism by which P. gingivalis accomplishes this
remains unclear [65].
To survive within the oral cavity, P. gingivalis must first adhere to oral structures, i.e.
epithelium, tooth surfaces, or most commonly primary bacterial colonizers. It does this
via adhesins present on its cell surface, which include fimbriae and haemagglutinins.
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After the initial adherence, P. gingivalis must colonize and survive within the subgingival
environment.
It achieves this via expression of molecules important for resisting oxidative stress,
nutrient acquisition, immune evasion, and it is thought, cellular internalization [63, 66].

1.6.1 Growth Requirements
P. gingivalis grows in vitro by forming smooth, raised colonies on blood agar plates. The
colonies appear creamy to white in color initially and turn to black in three to four days
with a specific unpleasant odor. The odor has been suggested due to the conversion of Lmethionine to methyl mercaptan along with other volatile sulfur compounds that play a
role in the virulence of the bacterium [67]. P. gingivalis is an asaccharolytic organism,
with a requirement for hemin (as a source of iron) and peptides for growth. At least three
hemagglutinins and five proteinases are produced to satisfy these requirements [57].
Bacterial colonies turn black due to the uptake of hemin from blood in the plates.
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Figure 5. Black-pigmented Porphyromonas gingivalis colonies.
On blood agar, P. gingivalis forms black-pigmented colonies.

Figure 6. Electron micrograph showing budding vesicles of P. gingivalis.
Adapted from P. gingivalis proteases and the unique protein transport system expressed by this
organism, J. Potempa.
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1.6.2 Virulence factors
P. gingivalis has some sneaky characteristics that makes it capable of evading or
suppressing many aspects of innate and acquired immunity [68]. The pathogen has a wide
spectrum of virulence factors including capsule, outer membrane vesicles, lectin like
adhesins, lipopolysaccharide, fimbriae and cysteine proteinases which make it a very
potent periodontal pathogen. P. gingivalis produces large amounts of arginine- and
lysine-specific cysteine proteinases in cell-associated and secretory forms [69]. These
enzymes, referred to as gingipains, cleave protein and peptide substrates after arginine
(gingipain R) and lysine residues (gingipain K), and it has been found that neither is
easily inhibited by host proteinase inhibitors [70].
P. gingivalis fimbriae are a critical factor for mediation of interaction of this bacterial
organism with host tissues, as P. gingivalis promotes both bacterial adhesion to and
invasion of targeted sites. P. gingivalis fimbriae are likely to interrupt the cellular
signaling via extracellular matrix proteins/integrins in periodontal regions. Fimbriae are
also thought to be critically important in invasive events of this bacterial organism to host
cells [71]. P. gingivalis adhesion and invasion requires the presence of two fimbriae,
termed the major and minor fimbriae. The major fimbria is composed of a 41-kDa protein
termed fimbrillin, encoded by the fimA gene [72]. The minor fimbria is comprised of a
67-kDa protein that is encoded by the mfa1 gene [73]. The major and minor fimbriae are
antigenically distinct, and they also differ based on amino acid composition and size [74].
A deficiency in the fimA gene leads to a diminished capacity to adhere to human gingival
fibroblasts and epithelial cells, and attenuation of periodontal bone loss in gnotobiotic-rat
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model. Short fimbriae reportedly mediate co-adhesion between P. gingivalis and S.
gordonii via adhesin-receptor interactions with streptococcal SspA and SspB surface
proteins (antigen I/II family) [75].
The lipopolysaccharide (LPS) of P. gingivalis is a key factor in the development of
periodontitis. Gingival fibroblasts, which are the major constituents of gingival
connective tissue, may directly interact with P. gingivalis and its bacterial products,
including lipopolysaccharide (LPS), in periodontitis lesions [76]. P. gingivalis LPS
induces pro-inflammatory cytokines, such as IL-1β, IL-6, and IL-8, which induce
periodontal tissue destruction.
Majority of P. gingivalis strains are encapsulated. The non-encapsulated strains would
probably be less efficient in progression of periodontitis due to their reduced ability of
both biofilm participation and tissue invasiveness. The capsule increases resistance to
phagocytosis [77].The capsule polysaccharides (CPS) down regulate the expression of
several pro-inflammatory cytokines including IL-6, IL-1β and IL-8 expression levels,
thereby compromising the host immune system and enhancing bacterial tissue invasion
[78].
The cysteine proteases of P. gingivalis are extracellular products of an important
etiological agent in periodontal diseases. Many of the in vitro actions of these enzymes
are consistent with the observed deregulated inflammatory and immune features of the
disease [79]. These enzymes are involved in both the destruction of periodontal tissues
and interrupting host-defense mechanisms through the degradation of immunoglobulins
and complement factors leading eventually to disease progression [80].
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Recent studies have implicated P. gingivalis in the etiology of rheumatoid arthritis, based
on its unique property among pathogens to express a citrullinating peptidylarginine
deiminase enzyme [81]. P. gingivalis peptidyl-arginine deiminase has the ability to
convert arginine residues in proteins to citrulline. Protein citrullination alters protein
structure and function; hence, peptidyl-arginine deiminase may be involved in
deregulation of the host’s signaling network and immune evasion. Furthermore,
accumulating evidence suggests a role for autoimmunity against citrullinated proteins in
the development of rheumatoid arthritis [82].
fimA Mutant (ΔfimA)
fimA fimbriae (long fimbriae) are a critical factor for colonization of P. gingivalis in
subgingival regions, as they promote both bacterial adhesion to, and invasion of, targeted
sites. The fimA gene exists as a single copy in the fim gene cluster (fim cluster). This
cluster contains 7 genes: fimX, pgmA, and fimABCDE. P. gingivalis is able to adhere to
and enter a variety of host cells, including macrophages, ﬁbroblasts, and epithelial and
endothelial cells, which is considered to be mediated by the interactions between long
ﬁmbriae and host components such as α5β1-integrin, β2-integrin (CD11 ⁄ CD18) and
lipid rafts [83]. The fimA mutant strain of P. gingivalis shows impaired invasion
capability of epithelial cells compared with wild-type strain, this suggests the
involvement of fimA in the bacterial interaction with surface receptor(s) on gingival cells
[84]. fimA-deﬁcient mutants were found to be relatively avirulent compared with wildtype strains of P. gingivalis at inducing periodontal bone loss [85].
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Mfa Mutant (Δmfa)
Short ﬁmbriae are shorter than long ﬁmbriae and can only be visualized when the latter
are absent. The short fimbriae of P. gingivalis are 0.1 to 0.5 µm in length and are
composed predominantly of mfa protein subunit [72]. Studies have shown that short
fimbriae play roles in adherence to host cells and co-aggregation. Mutants of P.
gingivalis that lack mfa (Δmfa), show impaired formation of both monospecies biofilms
as well as heterotypic biofilms with S. gordonii [86]. Abundance of mfa protein on the
cell surface may disrupt physical parameters of fimA fimbrial surface presentation and
impede the ability of fimA fimbriae to activate their cognate integrin receptors.
ndk Mutant (Δndk)
Physically stressed, infected or dying cells release small molecules called “danger
signals” that specifically interact with “danger signal receptors” on neighboring cells to
alter the immune response and control colonization by pathogens [86]. Among these
host-derived molecules, ATP, contributes to bacterial clearance by stimulating the
secretion of cytokines, recruitment of immune cells, and sensing of pathogens. Recent
studies suggest that extracellular ATP (eATP) released from immune cells can directly
function as a sensor against intracellular pathogens upon ligation of the purinergic
receptor, P2X7 [87].The P2X7 receptor has recently emerged as an important multi-level
mediator in controlling intracellular infections by regulating the innate immune response,
apoptosis, intracellular trafficking, and generation of reactive oxygen species (ROS) [88,
89].
P. gingivalis, is capable of intracellular survival, replication, and intercellular spreading
within the gingival epithelium, can withstand the challenge of host-mediated immune
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responses working to destroy pathogens and interrupt their colonization [90]. P.
gingivalis can diminish eATP/P2X7 receptor-mediated apoptosis of primary GECs.
Secretion of a nucleoside-diphosphate-kinase (ndk) homolog by the P. gingivalis has
been proposed to consume eATP, thereby inhibiting P2X7 ligation [91]. A ndkdeficient P. gingivalis mutant (Δndk) lacked the ability to inhibit ROS production and
persist intracellularly following eATP stimulation. Treatment with recombinant ndk
significantly diminished eATP-evoked ROS production [92]. We therefore proposed that
a ndk mutant strain would show reduced expression of Zeb1 compared to wild-type strain
of P. gingivalis.

1.7 Gingival Epithelial cells
The gingival epithelial comprise the epithelial tissue that covers the external surface of
the gingiva as well as the epithelium lining the gingival sulcus and the junctional
epithelium The gingival epithelium is subdivided into 3 sections, the oral epithelium,
the secular, and the junctional epithelium. The oral epithelium extends from the
mucogingival junction to the gingival margin. It is continuous with the sulcular
epithelium that lines the lateral aspect of the gingival sulcus. The junctional epithelium
forms the dentoepithelial junction apical to the sulcus. Its coronal end forms the bottom
of the gingival sulcus and is overlapped by the sulcular epithelium. These epithelia differ
from one another in their function and, therefore, in some of their histological
characteristics.
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Figure 7. Anatomy of the three areas of the gingival epithelium interface with the connective
tissue.
Adapted from Clinical Periodontology and Implant Dentistry 5th by Jan Lindhe.

The major cells within the epithelium are epithelial cells, and together these form a dense
structure joined by cell-cell junctions and cell adhesion receptors, including integrins.
The oral epithelium is a stratified, squamous epithelium, which may or may not be
keratinized. There are three distinct layers within the epithelium. These are known as the
basal layer, spinous layers (prickle cell layers) and superficial layers. The cytoskeleton of
epithelial cells, and indeed all eukaryotic cells, functions as a cellular scaffold. The
dynamic nature of the cytoskeleton aids in intracellular trafficking, mitosis and cellular
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migration [93]. Three types of protein filaments form the cytoskeleton, and these are
known as intermediate filaments, microtubules and actin filaments.
The gingival epithelial cells (GECs) constitute a very important tool in simulating the
interaction between periodontal pathogens and host cells in vitro. They are the first to
encounter the colonizing bacteria in the oral cavity and are thereby, well-known to play
an important role in the host-bacterial environment. Several studies have shown the
significant role of gingival epithelial cells in the immunological interplay, alongside
being the first line of defense i.e. barriers against pathogens. The immunological
modulation of epithelial cells is essential for the initiation and progression of
periodontitis [94].

1.7.1 Telomerase Immortalized Gingival Keratinocytes (TIGKs)
Keratinocytes form a predominant cellular component of the epithelial surface of oral
mucosa. The culture of keratinocytes is necessary for wide applications like the treatment
of burns, surgical correction of a mucosal defect, in developing model systems for in
vitro research experiments, gene therapy etc. [94]. Primary gingival epithelial cells have a
ﬁnite lifespan in culture of about nine passages, after which they cease replicating and
enter senescence state [95]. The limited lifespan of somatic cells in culture can be
triggered by progressive telomere shortening through a p53-/p21cip1-dependent
senescence mechanism [96, 97].
The enzyme telomerase contains a catalytic subunit, hTERT, expressed solely in germ
cells and immortal cancer cells [98]. Introduction of hTERT into ﬁbroblasts (which are
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mesenchymal cells responsible for much of the synthesis of extracellular matrix in
connective tissues) and some epithelial cells confers telomere maintenance and unlimited
replicative potential. The replication potential of these cell types during serial passaging
is generally limited by a telomere independent mechanism mediated by the attenuated
repression of CDKN2A (cyclin-dependent kinase inhibitor 2A), which encodes
p16INK4A and p14ARF. The function of p16INK4 is to attenuate Cdk4/6
phosphorylation of retinoblastoma protein and thus promote cell cycle arrest, whereas
p14ARF functions in the p53 pathway to inhibit MDM2-mediated degradation of p53 and
promote p53-mediated transcriptional activation (e.g. p53-/p21cip1-dependent
senescence) [99]. Transduction of cells with bmi1 (BMI1 polycomb ring ﬁnger
oncogene), a natural repressor of CDKN2A, facilitates immortalization upon subsequent
expression of hTERT [100]. Keratinocytes immortalized by bmi1 + hTERT display
unaﬀected cell morphology, growth control and diﬀerentiation potential [101].

1.7.2 Immortalization of gingival epithelial cells with human telomerase reverse
transcriptase
GECs were immortalized with bmi1 transduction followed by human telomerase reverse
transcriptase (hTERT) by the Rheinwald Laboratory at the Harvard Skin Disease
Research Center [101]. GECs were cultured in keratinocyte serum-free medium (K-SFM;
Invitrogen, Carlsbad, CA, USA) supplemented with 0.4 mM calcium chloride, 25µg/mL
bovine pituitary extract and 0.2 ng/mL epidermal growth factor. Cells were transduced
with amphotropic BABE bmi1.puro retroviral supernatants with 2µg/mL polybrene
(Sigma-Aldrich, St Louis, MO, USA) for 6 h. Cells were subcultured in K-SFM and
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subjected to drug selection (0.5 lg/mL puromycin) for 7 d. GECs previously bmi1
transduced were then transduced in a similar manner with amphotropic Wzl-TERT.Bsd
retroviral supernatants with polybrene followed by subculture and drug selection
(5µg/mL blasticidin) in K-SFM [102].

1.8 Study Rationale, Hypothesis, and Aims
To further advance our knowledge of the role of P. gingivalis in the up-regulation of
EMT markers, we proposed the following hypothesis and aims:
In this study, we hypothesized that P. gingivalis infection up-regulates the expression of
ZEB1 and vimentin in human oral epithelial cells, hence an increased invasiveness of
such infected cells.

Specific Aim #1: To evaluate the regulation of Zeb1 expression in P. gingivalis ATCC
33277 strain infected TIGK cells at the transcriptional levels.
Specific Aim #2: To determine the mechanism through which P. gingivalis up-regulates
Zeb1 mRNA expression.
Specific Aim #3: To examine the changes in vimentin, and Zeb1 mRNA expression
levels in TIGK cells challenged by P. gingivalis.
Specific Aim #4: To demonstrate that the up-regulation of Zeb1 in P. gingivalis infected
TIGK cells would enhance their invasiveness and to determine whether knockdown of
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ZEB1 would have any effect on vimentin expression as well as invasiveness of P.
gingivalis infected TIGK cells.

The overall goal is to evaluate how P. gingivalis in OSCC patients with chronic
periodontitis may play a role in the enhanced invasion of OSCC, as well as identify the
virulence factors or signaling pathways that might be helpful therapeutic targets in
hindering the progression of EMT, which is the initiating step in the invasion of OSCC.
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CHAPTER II
MATERIALS AND METHODS
2.1 Bacterial Stains and Growth Condition
P. gingivalis strains WT ATCC 33277 and mutants ΔfimA, Δmfa and Δndk were cultured
anaerobically (80% N2, 10% H2, 10% CO2) at 37°C in Trypticase soy broth(TSB) (BDBBL) supplemented with 1 mg/ml yeast extract, 5 μg/ml hemin and 1 μg/ml menadione.
Plate-cultured laboratory strains were grown on Trypticase soy broth (BBL-BD)
supplemented with 1 mg/ml yeast extract, 5 μg/ml hemin and 1 μg/ml menadione,
supplemented with 10% defibrinated sheep blood (BD-BBL). Antibiotics were used,
when appropriate, at the following concentrations: 5 µg/ml erythromycin (Δmfa and
Δndk) and 1 µg/ml tetracycline (ΔfimA). P. gingivalis strains were stored at -80°C as
frozen glycerol stocks and streaked onto TSB-blood agar plate. For use in experiments, P.
gingivalis was sub-cultured from a TSB-blood agar plate into broth. Overnight broth
cultures were used in experiments. An overnight subculture of OD 0.5-0.8 was used for
infection.
2.2 Cell Culture
Telomerase immortalized gingival keratinocytes (TIGKs) were cultured in Dermalife-K
serum free keratinocyte culture medium (Lifeline cell technology) containing the
supplements, Transferrin, rh TGF-α, rh Insulin, Epinephrine, L- Glutamine,
Hydrocortisone and Extract-P. Cells were cultured in a humidified chamber at 37°C, 5%

30

CO2. Medium was changed every 2-3 days and cells were passaged when 80-90%
confluent.
Cells were passaged by washing twice with phosphate buffered saline (PBS) and
incubating with 0.05%Trypsin/0.53mM EDTA (warmed in water bath prior to usage) at
37°C for 5-10 minutes (dependent on the cell type), until cells lifted from the surface of
the flask. Dermalife-K serum free keratinocyte culture medium was added to the cell
suspension to inhibit the enzymatic activity of the Trypsin/EDTA, and cells were
centrifuged at 1000 rpm for 5 minutes. The supernatant was removed, the cell pellet resuspended in medium and re-seeded at 1.0 x 106 cells/T75 flask. The cells were seeded
into 6-well plates at 30% confluence and infected when 80% confluence was attained
(approx. 1.0 x 106 cells/well). Cells were maintained as frozen stocks.

2.3 Infection Conditions
After TIGK cells attained 80% confluence on 6-well plates, culture media was replaced
by fresh media one day prior to when infection was carried out. TIGK cells were infected
with P. gingivalis strains WT ATCC 33277, ΔfimA, Δmfa, Δndk already described
mutants at multiplicity of infection (MOI) 50 and 100 for 6 hours, after which the culture
media was replaced by fresh media and incubated overnight. Non-infected TIGKs served
as a control for all conditions.
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2.4 Quantitative RT-PCR (qRT-PCR) analysis of mRNA expression
2.4.1 mRNA Isolation
Total RNA was purified from TIGK cells using the PerfectPure RNA Cell Kit (5 Prime).
Cultured TIGK cells were lysed using TCEP (0.5M) and lysis solution (5 Prime). Lysed
cells were then homogenized using 18 gauge needle and 3 ml syringe, thus releasing
RNA into the lysis solution. All the samples were run through a 5 PRIME PRECLEAR
column to remove any leftover debris following homogenization. The column binds
RNA, while proteins, DNA and other impurities were washed away with wash buffer.
Residual DNA was removed by on-column Dnase digestion. The DNA fragments and
DNase were then removed by subsequent washing. RNA was eluted from the column
using 50 μl of RNase-free water. A small volume of the purified RNA was used for
quantitative and qualitative analysis. The remaining RNA was stored at -80°C.

2.4.2 RNA analysis with NanoDrop
Quantification and purity of total RNA was assessed by using a NanoDrop 2000®
spectrophotometer (Thermo Scientific). RNA absorbs at 260 nm and the ratio of the
absorbance at 260 and 280 nm is used to assess the RNA purity. Pure RNA has an
A260/A280 value of 1.8-2.0, depending on how the measurement is performed and the
source of presumed contaminants.
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2.4.3 cDNA Synthesis for mRNAs

Complementary DNA was synthesized with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) following the manufacturer’s protocol. Reverse
transcription reactions were carried out for each RNA sample, subsequently followed by
first strand cDNA synthesis from 2 μg of the total RNA samples. The samples were
cooled to 4 °C, and stored at -20 °C until quantitative (q)RT – PCR.
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Table 1
The components used to synthesize cDNA

Reagent

Volume (μl)/20 μl Reaction

10x RT buffer

2.0

25x dNTP Mix (100mM)

0.8

10x RT Random Primers

2.0

MultiScribe Reverse Transcriptase

1.0

Nuclease-free H20

4.2

Total

10.0

Reverse transcription was performed using the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Each 20 μl consists of 10 μl of 2x RT master mix, and 10 μl of RNA sample.

2.4.4 SYBR Green real-time qRT-PCR assays
Power SYBR® Green PCR Master Mix (Applied Biosystems) was used in the real time
PCR reaction according to the manufacturer’s suggested protocols. Specific mRNA
targets (Zeb1, and vimentin) were analyzed, using GAPDH as the house keeping
gene/endogenous control. Signals for mRNA transcripts were determined by qRT-PCR
on 1:10 diluted cDNA. To prevent amplification of genomic DNA, forward and reverse
primers for each transcript were designed to target separate exons, spanning at least one
intron with a size of 200 bp or more. The primer sequences used for qRT-PCR can be
found in Table 3. Each sample was run in triplicate for three different set of experiments.
The relative gene expression was calculated using the comparative CT (ΔΔCT) / 2-ΔCt
method, where ΔCt = Ct (target RNA) − Ct (GAPDH) [103].
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Table 2
The reagents used in SYBR Green real-time qRT-PCR

Reagent

Volume (μl)/20 μl reaction

Forward Primer

0.50

Reverse Primer

0.50

Power SYBR Green PCR Master Mix

10.0

Nuclease-free H20

7.00

Total

18.00

Each 20 μl reaction consists of 18 μl master mix, and 2 μl cDNA sample.

Table 3
List of primers used for SYBR Green real-time qRT-PCR

Name

Forward

Reverse

ZEB1

5’-GCACCTGAAGAGGACCAGAG-3’

5’-TGCATCTGGTGTTCCATTTT-3’

Vimentin

5’-GGAACAATGACGCCCTGCGCCA-3’

5’-AGTTAGCAGCTTCAACGGCAAA-3’

GAPDH

5’-ACCACAGTCCATGCCATCAC-3’

5’-GGCCATGCCAGTGAGCTTCC-3’
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2.5 Quantitative RT-PCR (qRT-PCR) analysis of miRNA expression.
2.5.1 microRNA Isolation by the 70% Ethanol method.
Small RNAs, including miRNA and short interfering RNAs (siRNA) were isolated from
TIGK cells using the PureLink® miRNA Isolation Kit. The kit is based on the selective
binding of small RNA molecules to silica-based membrane in the presence of 70%
ethanol. TIGK cells were harvested by the addition of 300 μl binding buffer and
homogenization using 18 gauge needle and 3ml syringe. This was followed by addition
of 70% ethanol and vortexing to optimize the binding conditions of all small RNA
molecules. All the samples were run through a spin cartridge column where small RNA
binds to the column membrane while ethanol and other impurities are washed away with
wash buffer. Contaminating DNA was removed by on-column Dnase digestion. RNA
was eluted from the column using 50 μl of RNase-free water. A small volume of the
purified small RNA was used for quantitative and qualitative analysis as described above.
The remaining small RNA was stored at -70° to -80°C.

2.5.2 cDNA Synthesis for miRNAs
Complementary DNA was synthesized with the TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems) following the manufacturer’s protocol. Reverse
transcription reactions were carried out for each small 5 ng RNA sample per 15 μl
reaction, subsequently followed by first strand cDNA synthesis from 2 μg of the total
RNA samples. The samples were then cooled down to 4 °C, and then stored at -20 °C
until qRT – PCR.
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Table 4
The components used to synthesize cDNA using specific microRNA Primers

Reagent

Volume (μl)/15 μl Reaction

10x RT buffer

1.50

dNTP Mix (100mM)

0.15

RNase Inhibitor

0.19

MultiScribe Reverse Transcriptase

1.00

Nuclease-free H20

4.16

Total

7.00

Reverse transcription was performed using the TaqMan® MicroRNA Reverse Transcription Kit (Applied
Biosystems). Each 15 μl reaction consists of 7 μl master mix, 3 μl primer, and 5 μl RNA sample.

2.5.3 TaqMan real-time qRT-PCR MicroRNA Assays.
Quantitative RT-PCR was carried out using an Applied Biosystems Step One Plus™
Real-Time PCR System as described above. Specific microRNA targets (miR-200b, miR200c) expression were analyzed, using RNU48 as the house keeping gene/endogenous
control. The PCR primers for miR-200b, miR-200c, and RNU48 were purchased from
TaqMan (Applied Biosystems). The relative gene expression was calculated using the
comparative CT (ΔΔCT) / 2-ΔCt method, where ΔCt = Ct (target miRNA) − Ct (RNU48)
[103].
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Table 5
The reagents used in TaqMan MicroRNA Assays

Reagent

Volume (μl)/20 μl reaction

Primer (forward and reverse)

10.00

TaqMan MicroRNA Assay Mix

1.00

cDNA

1.33

Nuclease-free H20

7.67

Total

20.00

Each 20 μl reaction consists of 18.67 μl master mix, and 1.33 μl cDNA sample.

2.6 Dual-Glo Luciferase Reporter Assay.
The ZEB1 gene promoters used for the Dual Glo Luciferase reporter assay were prepared
by PCR amplification of human genomic DNA. The plasmids Z1p.1000-Luc contains 912bp to +43bp of the human ZEB1 gene (965 base pairs), Z1p-400-Luc contains -367bp
to +43bp (417 base pairs), Z1p.196-Luc contains -212bp to +43bp (265 base pairs
including Exon 1, 212 base pairs excluding Exon 1), all representing specific regions just
upstream of ZEB1 gene that acts as a binding site for transcription factors were inserted
into a promoterless Luciferase reporter vector (pGL3-Basic, Promega, Madison, WI).
TIGK cells suspension in 100 µl of growth medium were seeded in 96-well plates (1.0 x
104/well) 24 h before transfection. A 3:1 FuGENE® 6 Transfection Reagent
(Promega):Plasmid ratio was used. 2 μg of plasmids (Z1p.1000-Luc, Z1p.400-Luc,
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Z1p.196-Luc) were co-transfected with control Renilla luciferase plasmid
(pGL4.73Rluc). The ratio of experimental plasmid to control plasmid was 10:2.
Luciferase assays were performed using the Dual-Glo Luciferase Assay (Promega). 48 h
after transfection, TIGK cells were infected for 24 h. After 24 h of infection, the 96-well
plate containing TIGK cells were removed from the incubator, 75 µl of Dual-Glo
Luciferase reagent was added into each well and then incubated for 15mins at room
temperature. Firefly luciferase activity was measured using the Victor X3 2030
Multilabel Reader (PerkinElmer).The activity of the Dual-Glo Luciferase reagent was
stopped by the addition of 75 µl Dual-Glo Stop & Glo reagent. The plate was again
incubated for another 15mins at room temperature, and Renilla luminescence was
measured. Background measurements for Firefly Luciferase was taken from nontransfected samples and Dual-Glo Luciferase reagent, while the background
measurements for Renilla Luciferase was taken from non-transfected samples containing
both Dual-Glo Luciferase reagent and Dual-GloStop & Glo reagent. Each firefly
luciferase activity was normalized to Renilla luciferase activity. All transfection
experiments were conducted in triplicate for three different set of experiments. Cell
lysates were transferred in triplicate to 96-well plates.

2.7 Transwell assay.
A transwell assay was carried using a Permeable Transwell Pore Polyester Membrane
Insert (0.4-µm pore size polycarbonate membrane, 24-mm diameter, Corning, Inc.,
Corning, NY) to evaluate the effect of P. gingivalis secreted soluble factors mediating
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changes in TIGK cells behavior in the absence of cell-cell contact. 80% confluent TIGK
cells were grown in 6-well plates at 37°C for 48 h. Transwell inserts containing P.
gingivalis at MOI of 50 & 100 in Dermalife-K serum free keratinocyte culture medium
(Lifeline cell technology) were inserted over each experimental well and further
incubated for another 24 h. After 24 h of incubation at 37°C, the transwell inserts were
discarded and total RNA was then isolated for qRT-PCR analyses of ZEB1, as described
above.

Figure 8. Schematic of a Transwell Permeable Support.
Corning Osteo Assay Surface Co-Culture System. The upper compartment contains P. gingivalis in cell
culture media, the lower compartment contains TIGK cells. Adapted from: The evolution of chemotaxis
assays from static models to physiologically relevant platforms.

2.8 Matrigel Invasion Assay.
In vitro cell invasion assays were analyzed as described previously [33] in a BD
BioCoat™ Matrigel™ Invasion Chamber (Two Oak Park, Bedford, MA, USA) according
to the protocol provided by the manufacturer. Cells were allowed to grow to
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subconﬂuency (75-80%) for 48 h. After detachment with trypsin, cells were washed with
PBS, resuspended in serum free medium and 2 ml of cell suspension (1.25×105 cells/ml)
was seeded unto the Matrigel-coated Transwell Membrane (upper chamber 8-µm pore
size). Chemoattractant (a 5% fetal bovine serum in cell culture medium) was added to the
bottom wells of the chamber. The BD BioCoat Matrigel Invasion Chambers were
incubated in a humidified tissue culture incubator, at 37°C for 24 h. Cells were infected
with P. gingivalis at an MOI of 50 & 100 for 24 h.
After incubation, non-invading cells were removed from the upper face of the membrane
by scrubbing using cotton swabs, and the cells that had migrated to the lower face of the
ﬁlters were ﬁxed with 100% methanol solution for 2 minutes, air-dried, and stained with
1% solution of toluidine blue for 2 minutes. Images of three random x20 magnification
ﬁelds were captured from each membrane and the number of migratory cells was
counted. The mean of triplicate assays for each experimental condition was used.

2.9 Transfection of TIGKs with short interfering RNA.
Approximately 0.8-1.0 x 106 of TIGK cells were plated in 6-well plates. After 24 h of
incubation, cells were transfected with 30 nM predesigned short interfering RNA
(siRNA) (siGENOME SMARTpool siRNA) targeting ZEB1 or control siRNA purchased
from GE Healthcare Dharmacon using LipoJet transfection reagent (SignaGen®
Laboratories) according to the manufacturer’s protocol. The cells were subsequently
incubated for 48 h to achieve knockdown of expression of the target gene. Following 48
h in transfection medium, the medium was replaced with fresh culture medium for
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another 24 h of incubation. Transfected cells were thereafter infected with P. gingivalis at
an MOI of 50 & 100 for 24 h. To determine the knockdown efficiency, total RNA was
isolated for qRT-PCR analyses of ZEB1 and vimentin expression, as described above.
Transfected cells were used in the Matrigel invasion assay as described above.

2.10 Statistical analysis
Significance of correlations was done using GraphPad Prism 6 (GraphPad Software, San
Diego, CA). All quantified data represents an average of at least triplicate samples from
three biological replicates or as indicated. Data are presented as mean, error bars
represent standard errors (SEs) of the mean. Differences were analyzed with one-way
ANOVA and Student t test where applicable. All tests were performed two tailed, and
statistical significance was set at P less than 0.05 (P < 0.05).

42

CHAPTER III
RESULTS
3.1 Vimentin and its transcriptional inducer, ZEB1 were up-regulated following P.
gingivalis infection of TIGK cells.
A relationship between periodontal disease and the invasion of OSCC have been
suggested, and P. gingivalis have been shown to occur frequently in the mouth of oral
cancer patients [13, 14]. In order to ascertain whether P. gingivalis could be involved in
the up-regulation of EMT markers in epithelial cells, we focused on ZEB1 which is a
crucial EMT inducer, as well as vimentin which is transcriptionally induced by ZEB1.
Increased ZEB1 mRNA levels was confirmed with qRT-PCR, expression was upregulated >1.7-fold at MOI 50 (P < 0.0008) and >3-fold at MOI 100 (P < 0.0001) in
infected groups compared with uninfected controls (Fig. 9). Increased vimentin levels
was also shown by qRT-PCR, vimentin mRNA was up-regulated >1.8-fold at MOI 50 (P
< 0.0011) and >3-fold at MOI 100 (P < 0.0012) in infected cells compared with
uninfected control groups (Fig. 10).
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Figure 9. P. gingivalis infection up-regulated ZEB1 mRNA expression.
Results from qRT-PCR analysis showed a significant higher expression of ZEB1 mRNA at MOI 50 (***P
< 0.0008), and MOI 100 (****P < 0.0001).

Figure 10. P. gingivalis infection up-regulated vimentin mRNA expression.
Results from qRT-PCR analysis showed a significant higher expression of ZEB1 mRNA at MOI 50 (**P <
0.0011), and MOI 100 (**P < 0.0012).
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3.2. P. gingivalis infection of TIGK cells enhances activity at the ZEB1 promoter
region
In order to investigate whether P. gingivalis infection has any effect on the human ZEB1
promoter, plasmid constructs Z1p.1000-Luc, Z1p-400-Luc, and Z1p.196-Luc (all
representing specific regions upstream of ZEB1 gene that acts as a binding site for
transcription factors) in Firefly luciferase reporter were transfected into TIGK cells. Data
were analyzed relative to pGL4.73Rluc in Renilla luciferase (control). Increased
promoter activity was confirmed in infected cells compared with uninfected cells. The
highest activity was detected at the Z1p.196-Luc promoter region, which was higher than
Z1p-400-Luc and Z1p, while the least activity was obtained at the Z1p.1000-Luc region
(Fig. 11). This result suggests that activities at these promoter sites are enhanced in the
presence of P. gingivalis infection, suggesting a significant role of P. gingivalis at
transcriptional level of ZEB1 expression.
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Figure 11. P. gingivalis infection enhances ZEB1 promoter activity in TIGK cells.
ZEB1 promoter activity was determined by co-transfection of TIGK cells with either Z1p.1000-Luc, Z1p400-Luc or Z1p.196-Luc, together with pGL4.73Rluc for 48 h, thereafter test samples were infected with P.
gingivalis for 24 h. Firefly Luciferase activity was measured by normalizing it to Renilla activity, results
shows effect of P. gingivalis infection at the different promoter region with a pronounced activity at the
Z1p.196-Luc region. A significant enhanced activity was noted between infected cells and non-infected
control samples Z1p.196-Luc (***P < 0.0127), Z1p.400-Luc (**P < 0.0001) and Z1p.1000-Luc (***P <
0.0272).
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3.3. Up-regulation of ZEB1 mRNA represses miR-200 family in P. gingivalis infected
TIGK cells.
It has been reported that Zeb1 expression is controlled by miRNAs of the miR-200 family
in a negative feedback loop fashion [54]. Therefore, we investigated if P. gingivalis
infection has a role to play in down-regulation of members of the miR-200 family (miR200b and miR-200c) which will lead to reduction in the repression of ZEB1 by miR-200
family. Our data showed that at early time points Zeb1 goes up without a decrease in
mir200 and at later time points Zeb1 remained up-regulated, while both miR-200b and
miR-200c were down-regulated (Fig 12), this shows that P. gingivalis infection having an
effect on ZEB1 at the transcriptional level, and soon as ZEB1 mRNA gets significantly
high, we get to see a drop in miR-200 levels which is consistent with ZEB1 negatively
regulating miR-200. As shown in Fig. 13, down-regulation of miR-200b and miR-200c
was confirmed using qRT-PCR. Expression was of miR-200b was down-regulated >0.8fold at MOI 50 and >0.5-fold at MOI 100 (P < 0.0001), while miR-200c was downregulated >0.6-fold at MOI 50 (P < 0.0001) and >0.4-fold at MOI 100 (P < 0.0002) in
infected groups compared with uninfected controls (Fig. 12). This result further stresses
the role of P. gingivalis in ZEB1 control.
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(A)

(B)

MOI 100

MOI 100
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(C)

MOI 100

Figure 12. Effect of P. gingivalis infection on the expression of Zeb1 and miR-200
family.
Results from qRT-PCR analysis shows relative mRNA expression of ZEB1, miR-200b and miR-200c after
6 h, 24 h, 48 h & 72 h of infection with P. gingivalis at an MOI of 100. (A) qRT-PCR shows a significant
higher expression of ZEB1 at 6 h (****P < 0.0001), highest expression at 24 h (****P < 0.0001), and
decrease but significant high level at 48 h (***P < 0.0008) and 72 h (**P < 0.0029). (B) qRT-PCR shows
levels of miR-200b remaining high at 6 h (***P < 0.0007), and significant lower at 24 h (****P < 0.0001),
at 48 h (***P < .0002) & 72 h (****P < 0.0001) miR-200b remained significantly low but a gradual
increase was noted between both time points. (C) qRT-PCR shows levels of miR-200c remaining high at 6
h (***P < 0.0001), and significant lower at 24 h (****P < 0.0001), at 48 h & 72 h (****P < 0.0001) miR200c remain significantly low but a gradual increase in mRNA level was noted between both time points.

49

(A)

(B)

Figure 13. P. gingivalis infection down-regulated miR-200 family.
Results from qRT-PCR analysis shows relative mRNA expression of miR-200b and miR-200c after 24 h of
infection with P. gingivalis at an MOI of 50 and 100. (A) qRT-PCR shows a significant lower expression
of miR-200b at MOI 100 (****P < 0.0001). (B) qRT-PCR shows a significant lower expression of miR200c at MOI 50 (****P < 0.0001) and MOI 100 (****P < 0.0002).
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3.4. P. gingivalis-oral epithelial cell-cell interaction is required for the up-regulation
of ZEB1.
Studies have shown that initial adherence and cellular internalization is required for the
survival and virulence of P. gingivalis [66, 104]. In order to determine whether
internalization of P. gingivalis is important for the up-regulation of ZEB1, we co-cultured
TIGK cells and P. gingivalis in the absence of cell-cell contact using a Transwell
assay. After 24 h of inserting Transwell inserts containing P. gingivalis at MOI of 50 &
100 in Dermalife-K serum free keratinocyte culture medium over each experimental well,
a significant reduction in the ZEB1 mRNA expression >0.4-fold was noted at MOI 50 (P
< 0.0001) and >0.6-fold at MOI 100 (P < 0.0003) in infected cells compared with
uninfected control groups (Fig. 14). This results suggest that contact between epithelial
cells and P. gingivalis is needed for the up-regulation of ZEB1.
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Figure 14. P. gingivalis-Epithelial cell-cell contact is required for the up-regulation of
ZEB1.
Using a Transwell assay to co-culture TIGK cells and P. gingivalis at an MOI of 50 and 100 for 24 h. qRTPCR analysis showed a significant reduction in the expression of ZEB1 at MOI 50 (****P < 0.0001), and
MOI 100 (***P < 0.0003).

3.5. P. gingivalis molecules have varying effect on the up-regulation of ZEB1.
The presence of P. gingivalis mfa gene have been shown to deter the epithelial invasion
potential of P. gingivalis, while the fimA gene does the reverse [84]. We examined the
role of the mfa gene fimA in the regulation of Zeb1 by testing mutants of P. gingivalis
with deletions in the mfa and fimA genes. The result showed that in the absence of mfa,
ZEB1 expression was significantly enhanced compared to the absence of fimA (P <
0.0014; Fig. 15 A). This effect was reversed in the mfa complemented strain (P < 0.006;
Fig. 15 C & D). This suggests that enhanced invasion of TIGK cells by P. gingivalis
would translate into up-regulation of the ZEB1 gene.
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Lack of the ndk gene in P. gingivalis mutant strains have been linked with apoptosis of
gingival epithelial cells [91] and activation of P2X7 receptors and intracellular ROS,
therefore we investigated whether the lack of this ndk gene would have effect on the
expression of ZEB1. Quantitative RT-PCR analysis showed a reduction in ZEB1 mRNA
levels (P < 0.0001; Fig. 15 A), however this effect was reversed in the completed strain
(P < 0.0001; Fig 15 E & F).

(A)

MOI 50
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MOI 100
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(D) MOI 100

(E)

MOI 50
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(F)

MOI 100

Figure 15. P. gingivalis molecules have varying effect on the up-regulation of ZEB1.
Results from qRT-PCR analysis shows relative mRNA expression of ZEB1 after 24 h of infection TIGK
cells with P. gingivalis WT 33277 and its mutant strains at an MOI of 50 and 100. (A) qRT-PCR shows a
significant higher expression of ZEB1 with fimA mutant (**P = 0.0044), mfa mutant (****P < 0.0001) and
a lower expression of ZEB1 with ndk mutant (****P < 0.0001) at MOI 50. (B) qRT-PCR shows a
significant higher expression of ZEB1 with fimA mutant (****P < 0.0001), mfa mutant (**P < 0.0001) and
a lower expression of ZEB1 with ndk mutant (****P < 0.0001) at MOI 100. (C) The effect of higher ZEB1
expression was reversed in the mfa complemented strain at MOI 50. (D) The effect of higher ZEB1
expression was reversed in the mfa complemented strain at MOI 100. (E) The effect of lower ZEB1
expression was reversed in the ndk complemented strain (*P = 0.0149) at MOI 50. (F) The effect of higher
ZEB1 expression was reversed in the mfa complemented strain (***P < 0.0002) at MOI 100.
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Figure 16. ZEB1 expression with P. gingivalis mutant strains infection in terms of their
relative invasiveness.
Results from qRT-PCR analysis shows relative mRNA expression of ZEB1 after 24 h of infection of TIGK
cells with P. gingivalis WT 33277 and its mutant strains at an MOI of 100.

3.6. P. ginivalis infection promotes invasive potential of TIGK cells.
To determine the effect of P. gingivalis infection on the invasive potential of epithelial
cells, we analyzed the invasion of P. gingivalis infected TIGK cells using the Matrigel
invasion assay. Compared with untreated controls, TIGK infected cells showed a
significant increase in the number of invading cells, hence a higher ability to invade the
Matrigel layer after 24 h of infection (P < 0.0001; Fig. 16).
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(B)

Figure 17. P. gingivalis infection promotes the invasiveness of TIGK cells.
(A) Representative images of non-infected (control) and P. gingivalis infected TIGK cells invading through
a Matrigel-coated transwell membrane with an 8-µm pore size (x20 magnification). (B) Cell invasion was
evaluated by counting cells invading through a Matrigel-coated transwell membrane with an 8-µm pore
size. Cells embedded within the Matrigel were counted under light microscope (x20 magnification). Results
showed significant increase in the number of invading cells after infection with P. gingivalis at MOI 50 and
100 (****P < 0.0001).
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3.7. Knockdown of ZEB1 by ZEB1-specific siRNA reduces the invasiveness of P.
gingivalis infected TIGK cells.
To verify whether ZEB1 up-regulation by P. gingivalis infection is responsible for
Vimentin expression and Matrigel invasion, we knockdown ZEB1 by transfection of
TIGK cells with ZEB1-specific siRNA. Following transfection and infection of TIGK
cells with P. gingivalis, ZEB1 mRNA levels was quantified using qRT-PCR to confirm
the action of the siRNA. Our results showed that ZEB1 was down-regulated >1.5 fold (P
< 0.001; Fig. 17). We found that the knockdown of ZEB1 decreased the mRNA
expression of vimentin, which was significantly down-regulated after 24 h >2 fold (P <
0.001; Fig. 18). This result is consistent with previously shown results.
In order to demonstrate that down-regulation of ZEB1 in transfected cells could affect
P.gingivalis modulated behaviors of TIGK cells, the ability of ZEB1 knockdown cells to
invade Matrigel was analyzed. There was a statistically significant reduction of invasion
by P. gingivalis infected cells when ZEB1 was knocked down (Fig. 19).
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(A)

61

(B)

Figure 18. Effect of knockdown of ZEB1 on the relative expression of ZEB1 mRNA
following P. gingivalis infection.
TIGK cells were transfected with control (siRNA control) or ZEB1 siRNA for 72 h, after which cells were
infected with P. gingivalis for 24 h. Knockdown of ZEB1 resulted in down-regulation of ZEB1 mRNA
expression at an MOI of 50 ( ***P < 0.0001; (A)) and MOI 100 (****P < 0.0001; (B)).
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(B)

Figure 19. Effect of knockdown of ZEB1 on the relative expression of vimentin
following P. gingivalis infection.
TIGK cells were transfected with control (siRNA control) or ZEB1 siRNA for 72 h, after which cells were
infected with P. gingivalis for 24 h. Knockdown of ZEB1 resulted in down-regulation of vimentin mRNA
expression at an MOI of 50 ( ***P < 0.0001; (A)) and MOI 100 (****P < 0.0001; (B)).
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Figure 20. Effect of ZEB1 knockdown on the invasiveness of P. gingivalis infected
TIGK cells.
(A) Representative images of non-infected (siRNA control transfected cells) and P. gingivalis infected
TIGK cells siRNA control and ZEB1 siRNA transfected cells) invading through a Matrigel-coated
transwell membrane with an 8-µm pore size (x20 magnification). (B) Cell invasion was evaluated by
counting cells invading through a Matrigel-coated Transwell membrane with an 8-µm pore size. Cells
embedded within the Matrigel were counted under light microscope (x20 magnification). Results showed a
significant increase in the number of siRNA control transfected cells and a decrease in number of ZEB1
siRNA transfected cells invading the Matrigel-coated membrane after infection with P. gingivalis at MOI
50 & 100.
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CHAPTER IV
DISCUSSION
A relationship between periodontitis and OSCC have been demonstrated by various
studies. P. gingivalis, a successful colonizer of the oral epithelium and periodontal
pathogen, has also been identified as an independent microbial factor that increases the
risk of orodigestive cancer death [13]. Within gingival squamous carcinoma tumors,
detection of P. gingivalis has been described [14]. This demonstrates the possibility of an
interaction between P. gingivalis and OSCC cells in cancer and metastasis and
progression. ZEB1, a crucial inducer of cancer metastasis has been described to be
expressed in many tumor cell lines like OSCC.
In this study, we identified a correlation between an increased expression of ZEB1 in oral
epithelial cells and P. gingivalis infection. Our results from ZEB1 reporter experiments
showed that P. gingivalis infection plays a part in the elevation of the transcriptional
activity of the ZEB1 promoter. Although the mechanism by which it does this is not yet
understood, we were able to show a significant effect of P. ginigivalis on ZEB1 at the
promoter level. These results buttresses the fact that periodontal infection plays a role in
the transcriptional regulation of ZEB1 as an EMT inducer.
miRNAs have varying effects on the regulation of genes in terms of embryonic
development and carcinogenesis. Due to this interest, several studies have shown the
reverse interrelation between the inhibitory effect of miR-200 family on ZEB1 and the
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ability of ZEB1 directly to directly inhibit the transcription of members of the miR-200
family. An increased expression of ZEB1 in epithelial cells has been correlated with a
down-regulation of the miR-200 family in-vivo [54]. In this study, we report that miR200b and miR-200c which are members of the miR-200 family are down-regulated in P.
gingivalis infected TIGK cells compared to un-infected cells. Our results showed that
there is an inverse relationship between the expression of miR-200 family (miR-200b and
miR-200c) and ZEB1 mRNA in TIGK cells. These data are in agreement with other
reports showing an inverse correlation between miR-200 family and ZEB1 expression in
epithelial cells [54]. This indicates that the post-transcriptional regulation of ZEB1 by the
miR-200 family via targeting its 3’UTR in the presence of P. gingivalis was attenuated,
thereby stressing a possible mechanism through which it affects OSCC migration and
invasion.
Vimentin have been reported to be transcriptionally activated by ZEB1, and a direct
relationship has been shown between the transcriptional regulation of ZEB1 and vimentin
[38]. We were able to demonstrate with our results that this relationship exists in the
presence of P. gingivalis infection with a significant up-regulation of ZEB1 and vimentin
mRNA levels. Knock down of ZEB1 prevented P. ginigivalis induced up-regulation of
vimentin, suggesting that the transcriptional factor ZEB1 is very crucial for the
progression of cancer metastasis even in the presence of P. gingivalis. There is also a
high likelihood that transcriptional regulators other than ZEB1 can play some role in the
transcriptional activation of endogenous vimentin as shown in this study, for example
ZEB2 is also a known transcriptional regulator of EMT genes [39].
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Previous studies have shown that initial adherence and cellular internalization is required
for the survival and virulence of P. gingivalis [63, 66]. Using a Transwell assay, were
able to show that a close interaction between of oral epithelial cells and P. gingivalis is
indeed required for the up-regulation of ZEB1. Not surprisingly, our results showed a
significant reduction in the mRNA levels of ZEB1 because contact between P. gingivalis
and epithelial cells is needed to be established for there to be inflammatory response or
release of inflammatory cytokines that would probably initiate signaling pathways for
ZEB1 expression.
Various virulence factors of P. gingivalis have been implicated in the initiation and
progression of periodontal disease. Presence of the short fimbriae been shown to deter the
epithelial invasion potential while the long fimbriae promotes invasion of P. gingivalis
[63]. The ndk gene have been shown to be crucial for the survival of epithelial cells once
invaded by P. gingivalis. We examined the role of these genes in the up-regulation of
ZEB1 by infecting TIGK cells with the relevant mutant strains. Our result showed that in
the absence of mfa, ZEB1 expression was significantly enhanced compared to noninfected cells. This effect was reversed with the mfa complemented strain. This suggests
that enhanced invasion of TIGK cells by P. gingivalis would lead to up-regulation of the
ZEB1 gene. The lack of ndk gene caused a significant lower expression level of ZEB1
mRNA, and this effect was reversed in the completed strain. These results may support
the idea that TIGK cells could get apoptosed in the absence of the ndk gene.

To gain further insight into whether P. gingivalis infection of oral epithelial cells could
enhance the up-regulation of EMT related genes as well as the invasiveness of infected
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cells, we used the Matrigel invasion assay to analyze the number of invading cells
following infection with P. ginigivalis. Interestingly, we found increased invasiveness of
TIGK cells in the presence of infection as compared to non-infected cells. Furthermore,
knockdown of Zeb1 reduced that invasion of P. gingivalis-infected cells. These results
suggest that the transcriptional factor ZEB1 could increase cancer metastasis in the
presence of P. gingivalis.
Overall, we found that the over-expression of ZEB1 and vimentin, and the downregulation of miR-200 family, as well as enhanced invasiveness of oral epithelial cells
was associated with P. gingivalis infection. This demonstrates that P. gingivalis could
potentially play a significant role in OSCC metastasis, although of course additional
factors are also involved. These results could be a starting point for improving the
understanding of the role of periodontal pathogens in tumor progression, as a
diagnostic/prognostic tool, and as a new tool for designing innovative therapeutic
strategies in OSCC patients with periodontitis.
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CHAPTER V
DIRECTIONS FOR FUTURE RESEARCH

The above study has demonstrated that P. gingivalis infection is an important factor to
consider in terms of expression EMT related genes. Our results has shown that the
periodontal pathogen, P. gingivalis plays a significant role in the up-regulation of ZEB1
which is an important inducer of EMT. It would be interesting to study other oral
pathogens to know whether they behave similarly to P. gingivalis, and whether they have
diagnostic/prognostic significance in the management of OSCC. The down-regulation of
specific transcription factors may prove a potential target for therapeutic intervention.
Running same sets of experiments using OSCC cells as model for epithelial cells ould be
a great idea, especially well differentiated and moderately differentiated cells to see how
they behave in the presence of P. gingivalis.
As fundamental science research further proceed to clarify the role of P. gingivalis in
EMT and progression of OSCC, it would be of great interest to look into signaling
pathways impacted by this periodontal pathogen in ZEB1 expression. Several studies
have suggested signaling pathways such as TGFβ–SMAD3, WNT–β-catenin, Notch,
PI3K–AKT pathways to be involved in the up-regulation of EMT-related markers. NFκB-dependent expression of ZEB1 have also been shown to repress E-cadherin
expression and to promote EMT, through up-regulation of transcription repressor
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function of ZEB1, which in turn represses the expression of miR-200 family. P.
gingivalis triggers cell innate immunity by activating the nuclear factor κB (NF-κB), a
process which leads to the NF-κB-dependent transcription of pro-inflammatory cytokines
such as interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor α. The study of the
involved signaling pathways could provide significant perception into understanding of
pathways that link P. gingivalis infection with the EMT transition.
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